WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 2:51 pm Sale | 2022-12-30 | 13G | Entrada Therapeutics, Inc. TRDA | WELLINGTON MANAGEMENT GROUP LLP | 1,010,351 3.220% | -2,103,655 (-67.55%) | Filing |
| 2022-02-04 09:17 am Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | WELLINGTON MANAGEMENT GROUP LLP | 3,114,006 9.980% | 3,114,006 (New Position) | Filing |